XT
BIAF icon

XTX Topco’s bioAffinity Technologies BIAF Stock Holding History

XTX Topco’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-520
Closed -$4.48K – 2583
2025
Q2 		$4.48K Buy
520
+100
+24% +$1.14K ﹤0.01% 2260
2025
Q1 		$3.28K Buy
420
+66
+19% +$1.21K ﹤0.01% 2314
2024
Q4 		$9.92K Sell
354
-21
-6% -$845 ﹤0.01% 2150
2024
Q3 		$23.4K Buy
+375
New +$22.5K ﹤0.01% 1815

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

XTX Topco's BIAF Position: Q3 2025 in Review

XTX Topco sold out of bioAffinity Technologies (BIAF) in Q3 2025, closing a stake of 520 shares — an estimated $4.48K sold.

XTX Topco first reported a position in BIAF in Q3 2024 and held it in 4 quarters. The position peaked at $23.4K in Q3 2024. 12 funds tracked by Wall St. Rank hold BIAF as of Q3 2025.

  • XTX Topco reported no remaining bioAffinity Technologies position as of Q3 2025 after selling out during the quarter.
  • XTX Topco sold 520 bioAffinity Technologies shares in Q3 2025, an estimated $4.48K.
  • XTX Topco first reported a position in bioAffinity Technologies in Q3 2024 and held it in 4 quarters.
  • XTX Topco's bioAffinity Technologies position peaked at $23.4K in Q3 2024.
  • 12 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.